Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Endonovo Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ENDV
Over the counter
8731
https://endonovo.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Endonovo Therapeutics Inc
Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc
- Mar 28th, 2024 1:03 pm
Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions
- Mar 4th, 2024 2:09 pm
Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million
- Dec 4th, 2023 2:15 pm
Endonovo's SofPulse® Secures Taiwan FDA Approval
- Oct 12th, 2023 1:07 pm
Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution
- Aug 22nd, 2023 1:07 pm
Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update
- Aug 8th, 2023 1:03 pm
New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.
- Jun 22nd, 2023 5:02 pm
Endonovo Pending Agreement to Develop Telehealth Division
- Jun 7th, 2023 1:07 pm
Endonovo Launches SofPulse® into the Veterans Administration
- May 2nd, 2023 1:03 pm
Scroll